D-0348-2023 Class II Terminated
FDA drug recall D-0348-2023 was initiated by RISING PHARMACEUTICALS on Feb 15, 2023 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Jun 14, 2024). Affected quantity: 12,216 bottles (100 count each).
Recall details
- Product Type
- Drugs
- Report Date
- Mar 1, 2023
- Initiation Date
- Feb 15, 2023
- Termination Date
- Jun 14, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12,216 bottles (100 count each)
Product description
Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC# 57237-119-01
Reason for recall
Failed Impurities/Degradation Specifications
Distribution pattern
Product was distributed to 16 distributors and 8 wholesalers who may have further distributed the product nationwide.
Code information
Batch #: NB101596, Exp. 04/30/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0348-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026